U.S. markets close in 6 hours 29 minutes
  • S&P 500

    3,630.58
    -4.83 (-0.13%)
     
  • Dow 30

    29,957.06
    -89.18 (-0.30%)
     
  • Nasdaq

    12,051.28
    +14.49 (+0.12%)
     
  • Russell 2000

    1,853.53
    +35.23 (+1.94%)
     
  • Crude Oil

    45.53
    +0.62 (+1.38%)
     
  • Gold

    1,810.20
    +5.60 (+0.31%)
     
  • Silver

    23.38
    +0.08 (+0.34%)
     
  • EUR/USD

    1.1902
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    0.8770
    -0.0050 (-0.57%)
     
  • GBP/USD

    1.3334
    -0.0025 (-0.19%)
     
  • USD/JPY

    104.4200
    -0.0600 (-0.06%)
     
  • BTC-USD

    19,156.09
    -110.56 (-0.57%)
     
  • CMC Crypto 200

    379.44
    +8.92 (+2.41%)
     
  • FTSE 100

    6,391.08
    -41.09 (-0.64%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Lifshitz Law Firm, P.C. Announces Investigation of Benefytt Technologies, Inc., Noble Energy, Inc., Maxim Integrated Products and Rexahn Pharmaceuticals, Inc.

·2 min read

NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) --

Benefytt Technologies, Inc. (BFYT)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of BFYT to Madison Dearborn Partners, LLC for $31.00 per share.

If you are a BFYT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Noble Energy, Inc. (NBL)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of NBL to Chevron Corporation (CVX).

If you are a NBL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Maxim Integrated Products (MXIM) – Analog Devices (ADI)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the proposed merger of MXIM and ADI.

If you are a MXIM or ADI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Rexahn Pharmaceuticals, Inc. (REXN)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of REXN to Ocuphire Pharma, Inc.

If you are a REXN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C. The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm, P.C.
Phone: 516-493-9780

Facsimile: 516-280-7376
Email: info@jlclasslaw.com